X-Zelit received a lot of attention and interest at the World Ag Expo this past week after winning the Top 10 Product competition. The product was recently released on the US market and is sure to begin changing the way we feed transition cows.
X-Zelit is a product for preventing clinical and subclinical hypocalcemia in dairy cows. It is added to the close-up ration at the rate of 17.6 ounces /500 grams per cow per day for the last 14 days before calving. When using X-Zelit, no other methods of prevention are necessary ie. calcium boluses or acidification of the ration (DCAD balance). Starting in 2017, X-Zelit will be undergoing a University study at Cornell, lead by Dr. Tom Overton.
How it works:
X-Zelit binds excess calcium from the close-up ration in the small intestine. Thereafter, the calcium leaves the cow through her feces. At this point, there is no calcium in the close-up ration available for absorption.
This activates the cow's natural process of mobilizing calcium from her bones/body reserves [triggering her parathyroid hormone (PTH)]. Triggering this process allows her to maintain an optimum calcium level at calving and into lactation.
Today preventing subclinical hypocalcemia is considered as consistently maintaining calcium levels at 8.6mg/dl (2.15 mmol/l) or higher at calving. X-Zelit is the only product on the market today that can achieve this result.
University studies spanning many years back clearly show the negative impacts of sub-clinical hypocalcemia on metabolic diseases, milk production, reproduction, immune function etc.
About Protekta Inc.:
Protekta Inc., founded in 2003, is a privately- owned corporation based in Lucknow, Ontario, Canada. Protekta distributes a variety of forward thinking products to the North American livestock industry.
